| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear pore | 8.93e-05 | 101 | 150 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.24e-04 | 14 | 150 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | anchoring junction | IL16 GFRAL RPLP0 DAB2 GRB2 TNS2 LIMS4 LIMS3 PGM5 KRIT1 CCDC88C SLC8A1 FAT2 CLCA2 PTPRK CDH6 WNK3 ALOX15B | 2.26e-04 | 976 | 150 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.73e-04 | 18 | 150 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.77e-04 | 20 | 150 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 7.53e-04 | 6 | 150 | 2 | GO:0097728 | |
| Domain | NPIP | 5.71e-08 | 14 | 149 | 5 | IPR009443 | |
| Domain | LRRC37AB_C | 1.98e-06 | 4 | 149 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 1.98e-06 | 4 | 149 | 3 | PF14914 | |
| Domain | LRRC37_N | 1.98e-06 | 4 | 149 | 3 | IPR032754 | |
| Domain | LRRC37 | 1.98e-06 | 4 | 149 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 1.98e-06 | 4 | 149 | 3 | IPR015753 | |
| Domain | Grip | 7.83e-05 | 11 | 149 | 3 | SM00755 | |
| Domain | GRIP | 7.83e-05 | 11 | 149 | 3 | PF01465 | |
| Domain | Ran_BP1 | 1.04e-04 | 12 | 149 | 3 | PF00638 | |
| Domain | RANBD1 | 1.04e-04 | 12 | 149 | 3 | PS50196 | |
| Domain | GRIP_dom | 1.04e-04 | 12 | 149 | 3 | IPR000237 | |
| Domain | GRIP | 1.04e-04 | 12 | 149 | 3 | PS50913 | |
| Domain | RanBD | 1.34e-04 | 13 | 149 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 1.34e-04 | 13 | 149 | 3 | IPR000156 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 9.94e-06 | 41 | 100 | 5 | MM15200 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 1.89e-05 | 8 | 100 | 3 | M26991 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.42e-05 | 49 | 100 | 5 | MM14837 | |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 3.79e-10 | 4 | 155 | 4 | 18055785 | |
| Pubmed | RPLP0 RGPD8 ACACB ACLY FAT3 NKRF FER1L6 FAT2 SYCP1 HERC1 DNAH5 | 9.34e-09 | 234 | 155 | 11 | 36243803 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | HBS1L RPLP0 HECTD4 FBRS NVL GPATCH8 POM121C TRRAP NKRF LARP4B UBAP2L SEC16A USP15 NUP153 | 1.26e-08 | 440 | 155 | 14 | 34244565 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RPLP0 RPS6KA5 CDK12 ACLY DAB2 GPATCH8 TRRAP MIER1 QSOX1 FASN MAP1S WDHD1 UBAP2L SEC16A ELF1 NUP153 HOMEZ | 7.56e-08 | 774 | 155 | 17 | 15302935 |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 22419166 | ||
| Pubmed | NRDE2 HBS1L HK3 TEX2 FBRS FRYL GPATCH8 MIER1 TIAM2 LARP4B TAOK3 RESF1 WDHD1 UBAP2L SEC16A HERC1 CAMTA1 NUP153 ZNF445 | 4.05e-07 | 1084 | 155 | 19 | 11544199 | |
| Pubmed | 4.81e-07 | 105 | 155 | 7 | 9628581 | ||
| Pubmed | 4.99e-07 | 15 | 155 | 4 | 14697343 | ||
| Pubmed | Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. | 8.63e-07 | 5 | 155 | 3 | 37163372 | |
| Pubmed | FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration. | 1.23e-06 | 42 | 155 | 5 | 29348145 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 3.00e-06 | 7 | 155 | 3 | 15710750 | |
| Pubmed | NRIP1 RGPD8 ACACB FBRS RGPD1 FASN RESF1 ZNF608 BRCA2 SEC16A HOMEZ | 3.05e-06 | 418 | 155 | 11 | 34709266 | |
| Pubmed | Acetoacetyl-CoA synthetase is essential for normal neuronal development. | 4.78e-06 | 8 | 155 | 3 | 23000407 | |
| Pubmed | HBS1L CDK12 ACLY NAP1L4 TRRAP NKRF NSD3 FASN UBAP2L SEC16A USP15 RGPD5 | 7.14e-06 | 549 | 155 | 12 | 38280479 | |
| Pubmed | A2M NRDE2 HBS1L ACADM CDK12 SIK3 TUBGCP4 NKRF TAOK3 AACS MARF1 IFT122 MGRN1 | 7.62e-06 | 650 | 155 | 13 | 38777146 | |
| Pubmed | 1.02e-05 | 10 | 155 | 3 | 23064749 | ||
| Pubmed | IL16 SUPT20H FAT3 FBRS GRB2 SIK3 POM121C TRRAP NKRF NSD3 LARP4B RESF1 ZNF608 SUN2 SEC16A CSMD1 UNC80 | 1.09e-05 | 1116 | 155 | 17 | 31753913 | |
| Pubmed | IPO8 ACACB CDK12 PCLO NAP1L4 GPATCH8 TUBGCP4 RESF1 SASS6 USP15 | 1.24e-05 | 396 | 155 | 10 | 26687479 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NRIP1 HBS1L SUPT20H PCLO FBRS GRB2 RESF1 ZNF608 SEC16A IFT122 | 1.30e-05 | 398 | 155 | 10 | 35016035 |
| Pubmed | 1.40e-05 | 11 | 155 | 3 | 17069463 | ||
| Pubmed | HBS1L ZNF407 POM121C CCDC88C LARP4B VPS13D FAT2 SACS SUN2 TMCC1 UNC80 | 1.44e-05 | 493 | 155 | 11 | 15368895 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | HBS1L CDK12 ACLY PCLO NAP1L4 OLA1 MAP1S SACS UBAP2L SUN2 SEC16A | 1.58e-05 | 498 | 155 | 11 | 36634849 |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 25835709 | ||
| Pubmed | LINGO-1 receptor promotes neuronal apoptosis by inhibiting WNK3 kinase activity. | 1.97e-05 | 2 | 155 | 2 | 23482566 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11371563 | ||
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 1.97e-05 | 2 | 155 | 2 | 11586358 | |
| Pubmed | The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis. | 1.97e-05 | 2 | 155 | 2 | 29565179 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 30947381 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 31604923 | ||
| Pubmed | 2.15e-05 | 257 | 155 | 8 | 16335952 | ||
| Pubmed | SUPT20H ACACB FBRS RGPD1 NAP1L4 GPATCH8 POM121C TRRAP MIER1 NKRF LARP4B RESF1 ZNF608 UBAP2L SEC16A MARF1 ELF1 HERC1 HOMEZ | 2.17e-05 | 1429 | 155 | 19 | 35140242 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.40e-05 | 13 | 155 | 3 | 31427429 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 2.49e-05 | 38 | 155 | 4 | 12791264 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | IPO8 ABCA13 CDK12 NVL NPIPA7 POM121C AUNIP CLCA2 TMEM14EP IL1R1 UNC80 | 4.03e-05 | 552 | 155 | 11 | 10737800 |
| Pubmed | Polymorphisms in innate immunity genes and risk of childhood leukemia. | 4.10e-05 | 206 | 155 | 7 | 20438785 | |
| Pubmed | Risk of meningioma and common variation in genes related to innate immunity. | 4.22e-05 | 207 | 155 | 7 | 20406964 | |
| Pubmed | Common variation in genes related to innate immunity and risk of adult glioma. | 4.35e-05 | 208 | 155 | 7 | 19423540 | |
| Pubmed | 4.48e-05 | 44 | 155 | 4 | 20200978 | ||
| Pubmed | 4.49e-05 | 209 | 155 | 7 | 36779422 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 25845235 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 20610895 | ||
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 5.90e-05 | 3 | 155 | 2 | 15744052 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 33414135 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 37801083 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 9569023 | ||
| Pubmed | Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate. | 5.90e-05 | 3 | 155 | 2 | 18455495 | |
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 21924255 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 11369229 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 29036223 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 21281598 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 37377173 | ||
| Pubmed | 5.90e-05 | 3 | 155 | 2 | 21726077 | ||
| Pubmed | 6.45e-05 | 152 | 155 | 6 | 38360978 | ||
| Pubmed | 7.14e-05 | 225 | 155 | 7 | 12168954 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NRIP1 SUPT20H ACACB SPEG GRB2 TRRAP VPS13D TAOK3 MAP1S HERC1 | 8.41e-05 | 497 | 155 | 10 | 36774506 |
| Pubmed | 9.17e-05 | 162 | 155 | 6 | 25826454 | ||
| Pubmed | 9.25e-05 | 101 | 155 | 5 | 10997877 | ||
| Pubmed | 9.27e-05 | 503 | 155 | 10 | 16964243 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MTIF3 NRDE2 SUPT20H RPLP0 CDK12 HECTD4 NAP1L4 SIK3 GPATCH8 TRRAP NKRF NSD3 SACS SUN2 CFAP45 | 1.06e-04 | 1082 | 155 | 15 | 38697112 |
| Pubmed | Identification of AMSH-LP containing a Jab1/MPN domain metalloenzyme motif. | 1.18e-04 | 4 | 155 | 2 | 12810066 | |
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 24356554 | ||
| Pubmed | 1.18e-04 | 4 | 155 | 2 | 9480752 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CDK12 SPEG HECTD4 FBRS FRYL POM121C TRRAP TIAM2 NSD3 CCDC88C FASN MAP1S KCNH2 SEC16A HERC1 | 1.34e-04 | 1105 | 155 | 15 | 35748872 |
| Pubmed | 1.37e-04 | 250 | 155 | 7 | 18660489 | ||
| Pubmed | 1.40e-04 | 529 | 155 | 10 | 14621295 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.42e-04 | 430 | 155 | 9 | 35044719 | |
| Pubmed | 1.44e-04 | 23 | 155 | 3 | 14662765 | ||
| Pubmed | NRIP1 ACACB LRRC37A3 FBRS RGPD1 SIK3 POM121C FER1L6 SLC38A1 WDHD1 AASS | 1.45e-04 | 638 | 155 | 11 | 31182584 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | NRIP1 TEX2 ZNF407 FRYL SLC38A1 LARP4B VPS13D SUN2 ELF1 CAMTA1 | 1.55e-04 | 536 | 155 | 10 | 15840001 |
| Pubmed | NRIP1 TEX2 ZNF407 FRYL SLC38A1 LARP4B VPS13D SUN2 ELF1 CAMTA1 | 1.60e-04 | 538 | 155 | 10 | 10512203 | |
| Pubmed | RPLP0 ACLY NVL FRYL TRRAP NKRF LARP4B FASN UBAP2L SEC16A NUP153 | 1.77e-04 | 653 | 155 | 11 | 22586326 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.89e-04 | 351 | 155 | 8 | 38297188 | |
| Pubmed | 1.94e-04 | 551 | 155 | 10 | 34728620 | ||
| Pubmed | 1.96e-04 | 5 | 155 | 2 | 22593055 | ||
| Pubmed | 1.96e-04 | 5 | 155 | 2 | 17235283 | ||
| Pubmed | 1.96e-04 | 5 | 155 | 2 | 10542228 | ||
| Pubmed | 1.96e-04 | 5 | 155 | 2 | 34048454 | ||
| Pubmed | Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring. | 2.09e-04 | 26 | 155 | 3 | 39152101 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 2.15e-04 | 269 | 155 | 7 | 29511261 | |
| Pubmed | 2.35e-04 | 27 | 155 | 3 | 18838386 | ||
| Pubmed | TEX2 DAB2 NAP1L4 SLC38A1 FASN VPS13D UBAP2L SEC16A USP15 NUP153 | 2.47e-04 | 568 | 155 | 10 | 37774976 | |
| Pubmed | RPLP0 RGPD8 ACACB PCLO RGPD1 FER1L6 FASN GUCY1A2 ZNF608 SACS CFAP45 SYCP1 MARF1 IFT122 IL1R1 PLXNA2 RGPD5 | 2.53e-04 | 1442 | 155 | 17 | 35575683 | |
| Pubmed | Novel genes differentially expressed in cortical regions during late neurogenesis. | 2.62e-04 | 28 | 155 | 3 | 17614941 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.66e-04 | 197 | 155 | 6 | 20811636 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.69e-04 | 370 | 155 | 8 | 22922362 | |
| Pubmed | 2.91e-04 | 29 | 155 | 3 | 38972757 | ||
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 26590148 | ||
| Pubmed | Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. | 2.93e-04 | 6 | 155 | 2 | 20709820 | |
| Pubmed | 2.93e-04 | 6 | 155 | 2 | 10982817 | ||
| Pubmed | Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. | 2.93e-04 | 6 | 155 | 2 | 19480842 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.97e-04 | 475 | 155 | 9 | 31040226 | |
| Pubmed | Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function. | 3.23e-04 | 30 | 155 | 3 | 27133129 | |
| Pubmed | HBS1L IPO8 RPLP0 RPLP0P6 ACLY NAP1L4 GRB2 OLA1 TRRAP LARP4B FASN RESF1 SUN2 SEC16A SPRTN USP15 | 3.24e-04 | 1335 | 155 | 16 | 29229926 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 3.45e-04 | 384 | 155 | 8 | 31059266 | |
| Pubmed | 3.51e-04 | 486 | 155 | 9 | 20936779 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MTIF3 IPO8 RPLP0 RGPD8 ACADM TEX2 PCLO NKRF LARP4B VPS13D AASS NDUFAF7 SUN2 SEC16A SASS6 HERC1 TMCC1 | 3.87e-04 | 1496 | 155 | 17 | 32877691 |
| Pubmed | Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. | 3.92e-04 | 32 | 155 | 3 | 25189868 | |
| Pubmed | 4.08e-04 | 7 | 155 | 2 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.08e-04 | 7 | 155 | 2 | 11353387 | |
| Pubmed | 4.08e-04 | 7 | 155 | 2 | 30944974 | ||
| Interaction | SIRT6 interactions | HBS1L RPLP0 RGPD8 ACLY FAT3 HECTD4 FBRS NVL GPATCH8 POM121C TRRAP NKRF LARP4B WDHD1 UBAP2L SEC16A USP15 NUP153 RGPD5 | 1.82e-07 | 628 | 148 | 19 | int:SIRT6 |
| Interaction | NPIPB6 interactions | 7.89e-06 | 18 | 148 | 4 | int:NPIPB6 | |
| Interaction | CLEC4A interactions | 1.10e-05 | 103 | 148 | 7 | int:CLEC4A | |
| Interaction | FBXL13 interactions | 1.72e-05 | 44 | 148 | 5 | int:FBXL13 | |
| Cytoband | 16p13.11 | 1.32e-08 | 23 | 155 | 5 | 16p13.11 | |
| Cytoband | 2q13 | 8.60e-05 | 68 | 155 | 4 | 2q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p22 | 4.42e-04 | 104 | 155 | 4 | chr2p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 6.46e-04 | 426 | 155 | 7 | chr16p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 1.07e-03 | 59 | 155 | 3 | chr2q13 | |
| Cytoband | 2p22.2 | 1.16e-03 | 15 | 155 | 2 | 2p22.2 | |
| Cytoband | 14q32.11 | 1.49e-03 | 17 | 155 | 2 | 14q32.11 | |
| GeneFamily | LIM zinc finger domain containing|LIM domain containing | 1.56e-04 | 4 | 93 | 2 | 1163 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.83e-04 | 161 | 93 | 6 | 593 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 9.20e-04 | 9 | 93 | 2 | 1234 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRIP1 SUPT20H NVL FRYL STAM SIK3 GPATCH8 TRRAP KRIT1 LARP4B TAOK3 WDHD1 BRCA2 PTPRK SACS IL1R1 USP15 TMCC1 NUP153 ADGRA3 | 1.14e-07 | 856 | 151 | 20 | M4500 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 5.32e-06 | 219 | 151 | 9 | M41199 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | RGPD8 RPS6KA5 CDK12 FRYL STAM SIK3 POM121C MIER1 QSOX1 UBAP2L NDUFAF7 MARF1 SLC26A6 NUP153 RGPD5 | 9.66e-06 | 680 | 151 | 15 | M41089 |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 2.18e-05 | 200 | 151 | 8 | M6653 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-10 | 184 | 154 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-10 | 184 | 154 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-10 | 184 | 154 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-08 | 157 | 154 | 8 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | Control-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 2.23e-07 | 180 | 154 | 8 | 47036eee4c128fbb443d1fc767b4de5cced93f0e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 195 | 154 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 195 | 154 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-07 | 196 | 154 | 8 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 160 | 154 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 160 | 154 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 169 | 154 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-06 | 172 | 154 | 7 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-06 | 172 | 154 | 7 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.93e-06 | 178 | 154 | 7 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.93e-06 | 178 | 154 | 7 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.50e-06 | 118 | 154 | 6 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 3.78e-06 | 185 | 154 | 7 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 4.36e-06 | 189 | 154 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 4.51e-06 | 190 | 154 | 7 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-06 | 192 | 154 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.83e-06 | 192 | 154 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 5.00e-06 | 193 | 154 | 7 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.17e-06 | 194 | 154 | 7 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-06 | 196 | 154 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.72e-06 | 197 | 154 | 7 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.91e-06 | 198 | 154 | 7 | e4cbe4032dba0da3fd46817ea9ad86ba9217f747 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 1.24e-05 | 147 | 154 | 6 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 153 | 154 | 6 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-05 | 156 | 154 | 6 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.87e-05 | 158 | 154 | 6 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 165 | 154 | 6 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.38e-05 | 165 | 154 | 6 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 169 | 154 | 6 | f2e20049a17eee533d49bd5f24a51962d123d132 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 169 | 154 | 6 | 4c6892551e9dec94fc62b3beab1e6d424639a1e9 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.91e-05 | 171 | 154 | 6 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.31e-05 | 175 | 154 | 6 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.31e-05 | 175 | 154 | 6 | 69ed3c7c45df6bef70f5f2ff003531160bf3b32b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-05 | 179 | 154 | 6 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.88e-05 | 180 | 154 | 6 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 3.88e-05 | 180 | 154 | 6 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Control / Disease state, Lineage and Cell class | 4.13e-05 | 182 | 154 | 6 | 31bb838cc2900f3c9da9f835d79d557a08abb928 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.13e-05 | 182 | 154 | 6 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 4.39e-05 | 184 | 154 | 6 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 4.39e-05 | 184 | 154 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.39e-05 | 184 | 154 | 6 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 4.39e-05 | 184 | 154 | 6 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 4.39e-05 | 184 | 154 | 6 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | IPF-Myeloid-Mast|IPF / Disease state, Lineage and Cell class | 4.39e-05 | 184 | 154 | 6 | c3baf21f10b45cf91ac99997a59f353bcf3de8b7 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 4.52e-05 | 185 | 154 | 6 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.52e-05 | 185 | 154 | 6 | a86a3a1a187a4d8d7762bc6d3dcb22c982178d22 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-05 | 185 | 154 | 6 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-Progen-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.52e-05 | 185 | 154 | 6 | a139e95d31af9866ed2d4618ad67557851b98ef3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-05 | 186 | 154 | 6 | f690e26b2ed024bd8ede494b8e9a00976fdc9734 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 186 | 154 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.94e-05 | 188 | 154 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 188 | 154 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.09e-05 | 189 | 154 | 6 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.09e-05 | 189 | 154 | 6 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 5.09e-05 | 189 | 154 | 6 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | normal_Lung-Fibroblasts-Undetermined|normal_Lung / Location, Cell class and cell subclass | 5.24e-05 | 190 | 154 | 6 | 30d4658bcc6796f0cdf54cc029f4bb904b13ef66 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 5.40e-05 | 191 | 154 | 6 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 191 | 154 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-05 | 191 | 154 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 191 | 154 | 6 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 5.40e-05 | 191 | 154 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-05 | 191 | 154 | 6 | 72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-05 | 191 | 154 | 6 | 6e7f589efc997f32175e0789c5ea7ca46e1389b8 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 191 | 154 | 6 | 3ce403e0beedb544edeb3ae6eb30267040d00c21 | |
| ToppCell | Control-Treg|Control / Disease group and Cell class | 5.55e-05 | 192 | 154 | 6 | 3a9a8ac2aa278adde848608f9bb92a002dbb9bcc | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.72e-05 | 193 | 154 | 6 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 5.72e-05 | 193 | 154 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.72e-05 | 193 | 154 | 6 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.88e-05 | 194 | 154 | 6 | 9588a9b4baebbae08e13d201d4b9dfcf0e6521fb | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 5.88e-05 | 194 | 154 | 6 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.05e-05 | 195 | 154 | 6 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.05e-05 | 195 | 154 | 6 | cab90c67a7b3119c0d0d2d5e84511c41dcb8765f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.05e-05 | 195 | 154 | 6 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | severe-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.05e-05 | 195 | 154 | 6 | 0fc3c605609c9e6bdea15d73c45def2188ae5fb1 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 6.23e-05 | 196 | 154 | 6 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-05 | 196 | 154 | 6 | fa42a8f8a11645fc733ce9c59c2a0599ecf2176d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.40e-05 | 197 | 154 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 6.40e-05 | 197 | 154 | 6 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.40e-05 | 197 | 154 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.40e-05 | 197 | 154 | 6 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.40e-05 | 197 | 154 | 6 | d2a4d7e92e91bcc47a7657da2e5c8a3ad7eb08ad | |
| ToppCell | mild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.40e-05 | 197 | 154 | 6 | 15230a54fa5903dd728de1a0ad633bd2d2c7a04d | |
| ToppCell | Severe_COVID-19-T/NK-CD4+_T_2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.59e-05 | 198 | 154 | 6 | c8c9343c19198b6534f8f07e74405e29b3a164bf | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.59e-05 | 198 | 154 | 6 | 85215015bb86ada0e871c413a4ecdc903a3785ca | |
| ToppCell | severe-dn_T|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.59e-05 | 198 | 154 | 6 | d4f2213af45ada47e6c62675f468ce05692db507 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 6.59e-05 | 198 | 154 | 6 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-05 | 198 | 154 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-05 | 198 | 154 | 6 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-05 | 198 | 154 | 6 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.59e-05 | 198 | 154 | 6 | 93773b1abbf46b39e320d628077bf94958b872a4 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.59e-05 | 198 | 154 | 6 | 812ffe7369bf83ae5071970934c8831611db9557 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.59e-05 | 198 | 154 | 6 | 38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.77e-05 | 199 | 154 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.77e-05 | 199 | 154 | 6 | 8e87ba32fcc1d45be73098e5baa6c9c6369b97df | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.77e-05 | 199 | 154 | 6 | 15d7b2479a1426dd8f38ef70225ce07f48f320b2 | |
| Disease | microglial activation measurement | 1.12e-05 | 59 | 146 | 5 | EFO_0010940 | |
| Disease | Down syndrome (biomarker_via_orthology) | 2.43e-05 | 2 | 146 | 2 | DOID:14250 (biomarker_via_orthology) | |
| Disease | trypanosomiasis (biomarker_via_orthology) | 1.45e-04 | 4 | 146 | 2 | DOID:10113 (biomarker_via_orthology) | |
| Disease | cardiovascular disease biomarker measurement, ankle brachial index | 2.41e-04 | 5 | 146 | 2 | EFO_0003912, EFO_0005278 | |
| Disease | muscular disease (implicated_via_orthology) | 2.41e-04 | 5 | 146 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | v-set and transmembrane domain-containing protein 4 measurement | 3.60e-04 | 6 | 146 | 2 | EFO_0803247 | |
| Disease | obsolete_red blood cell distribution width | SLC17A2 MTIF3 NRIP1 HBS1L CDK12 LRRC37A2 HECTD4 RGPD1 NVL ZNF407 SIK3 NSD3 TAOK3 RESF1 HERC1 TOX2 WNK3 | 3.75e-04 | 1347 | 146 | 17 | EFO_0005192 |
| Disease | alcohol consumption measurement | GFRAL ACACB RPS6KA5 CDK12 PCLO OLA1 SLC38A1 SLC8A1 LINGO1 ZNF608 PTPRK PAFAH2 CAMTA1 CSMD1 DNAH5 PLXNA2 | 4.50e-04 | 1242 | 146 | 16 | EFO_0007878 |
| Disease | Cerebral ventriculomegaly | 5.02e-04 | 7 | 146 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 5.02e-04 | 7 | 146 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 5.02e-04 | 7 | 146 | 2 | C0009451 | |
| Disease | C-C motif chemokine 1 measurement | 5.02e-04 | 7 | 146 | 2 | EFO_0008041 | |
| Disease | Fetal Cerebral Ventriculomegaly | 5.02e-04 | 7 | 146 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 5.02e-04 | 7 | 146 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 5.02e-04 | 7 | 146 | 2 | C0549423 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 6.68e-04 | 8 | 146 | 2 | EFO_0801373 | |
| Disease | Congenital Hydrocephalus | 6.68e-04 | 8 | 146 | 2 | C0020256 | |
| Disease | Aqueductal Stenosis | 6.68e-04 | 8 | 146 | 2 | C2936786 | |
| Disease | Hydrocephalus | 8.56e-04 | 9 | 146 | 2 | C0020255 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 8.56e-04 | 9 | 146 | 2 | EFO_0010613 | |
| Disease | Malignant neoplasm of breast | NRIP1 GFRAL HK3 ACADM LRRC37A2 BCHE SIK3 OLA1 PPP1R3A FASN LRRC37A GUCY1A2 CLCA2 BRCA2 | 9.22e-04 | 1074 | 146 | 14 | C0006142 |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 1.07e-03 | 10 | 146 | 2 | EFO_0801535 | |
| Disease | OCIA domain-containing protein 1 measurement | 1.07e-03 | 10 | 146 | 2 | EFO_0008252 | |
| Disease | spleen volume | 1.27e-03 | 43 | 146 | 3 | EFO_0600047 | |
| Disease | oncostatin-M measurement | 1.55e-03 | 12 | 146 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 1.55e-03 | 12 | 146 | 2 | EFO_0020833 | |
| Disease | phosphatidylcholine 40:7 measurement | 1.83e-03 | 13 | 146 | 2 | EFO_0021477 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.96e-03 | 50 | 146 | 3 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.08e-03 | 51 | 146 | 3 | EFO_0022331 | |
| Disease | creatinine measurement, glomerular filtration rate | 2.77e-03 | 117 | 146 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | multiple sclerosis | 2.89e-03 | 594 | 146 | 9 | MONDO_0005301 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 3.00e-03 | 58 | 146 | 3 | EFO_0022338 | |
| Disease | Antibody Deficiency Syndrome | 3.15e-03 | 17 | 146 | 2 | C0003257 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 3.22e-03 | 122 | 146 | 4 | EFO_0009264, EFO_0010724 | |
| Disease | Obesity | 3.61e-03 | 205 | 146 | 5 | C0028754 | |
| Disease | acylcarnitine measurement | 3.71e-03 | 127 | 146 | 4 | EFO_0005059 | |
| Disease | cortical surface area change measurement, age at assessment | 3.93e-03 | 19 | 146 | 2 | EFO_0008007, EFO_0021503 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 4.14e-03 | 65 | 146 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | COVID-19 (is_implicated_in) | 4.80e-03 | 21 | 146 | 2 | DOID:0080600 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAFGGNPKSVTLFGE | 211 | P06276 | |
| NPKSVTLFGESAGAA | 216 | P06276 | |
| VGQPFLKAEGSSNSV | 1416 | Q9NYV4 | |
| ETAAFQASGSQPVGK | 1306 | Q9Y6Y1 | |
| DPSAGTGSQKFILQA | 456 | P32519 | |
| ASVKGNEGTLLSPNF | 1106 | Q96PZ7 | |
| SNFVPTNVGSKAFGR | 106 | P10092 | |
| KAVEQGGAFSNPETL | 646 | Q86V21 | |
| FRNGKLFPATGNSTN | 641 | Q8IWK6 | |
| FTGTGNVSKGAQAIF | 221 | Q9UDR5 | |
| QVNSLPGSITKAGDF | 1161 | P01024 | |
| DFFKNISSVGTGNLV | 1691 | Q86UQ4 | |
| NKAFTGFIVEADTPG | 216 | P11310 | |
| LFSEGGNFSPKEINS | 1046 | Q9P1Z9 | |
| FQLEGGLKQFSFPLS | 181 | P01023 | |
| LFDQIPVSSGFSKNG | 5161 | Q9HC84 | |
| AFTKNGSGAVFPVAG | 126 | O00391 | |
| GSLFGFSFNAPLKSN | 1566 | Q99666 | |
| GSLFGFSFNAPLKSN | 1566 | O14715 | |
| GIVGLPNVGKSTFFN | 26 | Q9NTK5 | |
| ANESGLNFISVKGPE | 636 | O15381 | |
| QAGFKESDVGFIPTS | 431 | Q9Y450 | |
| SFLKTIFPSQNGHDG | 66 | Q9UND3 | |
| PGSSIQTKSNLFEAF | 51 | Q8WWG1 | |
| ILGQNGFFVSPSDSL | 301 | Q15124 | |
| GFKPSSGTVQELNFR | 661 | O00763 | |
| QNGFSVKSSPNPFVG | 386 | P98082 | |
| NFFNPLKASGDGESL | 291 | Q99733 | |
| DSAGTAFNLGPTVKQ | 1426 | O60309 | |
| GGASTQITFLPQFEK | 201 | O75356 | |
| TAKLSFEQGGSEFVP | 1151 | Q9HBG6 | |
| KGGFAPAETIVNSNG | 76 | P0CW19 | |
| KGGFAPAETIVNSNG | 76 | P0CW20 | |
| FTVLVNGGSNPKSSF | 261 | Q66K74 | |
| DSAGTAFNLGPTVKQ | 1426 | A6NM11 | |
| DSAGTAFNLGPTVKQ | 1426 | A6NMS7 | |
| GVSQQFSLPSFKIDF | 166 | O60291 | |
| VSFVSGDVGNAPGFK | 1596 | Q15751 | |
| GFGNVSPNTNSEKIF | 626 | Q12809 | |
| NTGFINGFTSPAFKP | 381 | Q92615 | |
| QNKPLFITAGLDSFG | 251 | Q8TCX1 | |
| VKTFGPFGSGSQDNL | 21 | Q9P219 | |
| ESLFGDIKSPAQGQS | 36 | Q9UL16 | |
| SEFSTDKGGPFTAVQ | 251 | Q9UKJ3 | |
| ATFSSRPQAVQGGKA | 221 | Q9H2K0 | |
| FTSGETFGQEKPASQ | 2361 | Q9Y6V0 | |
| AKPGDSLAQAFNITS | 316 | O75051 | |
| ITKGNNGSAFRVTPD | 3466 | Q9NYQ8 | |
| IFSVSKQFQSLPGFE | 321 | Q9H295 | |
| FPGLQQLFLKGFTSA | 2056 | O94915 | |
| FETFGSSQLPDKGAQ | 846 | Q14005 | |
| AFEDKINAGSNTPGS | 411 | Q14D04 | |
| FAKLNSSVFPEGSGE | 931 | Q9H7Z3 | |
| KNFTSPNGTIESPGF | 151 | O60462 | |
| VSPQDFSFSKNGLLS | 806 | P48552 | |
| GAAFFTGQIFTKASP | 636 | O00522 | |
| NKTFAFISNQPGEGE | 526 | Q96FE5 | |
| EEFFIKQGPSSGNVS | 201 | Q9UGJ1 | |
| GASPFTVDGEKNSQA | 251 | O75582 | |
| SFLKTIFPSQNGHDG | 66 | F8WFD2 | |
| NNVASSAVGTALPKF | 2346 | Q9Y4D8 | |
| FLKTIFPSQNGHDGS | 86 | E9PIF3 | |
| QNTGLGPEKTSFFQA | 126 | P05388 | |
| VNKQGLQLGFSFSFP | 156 | P52790 | |
| APGDFSLSVKFGNDV | 91 | P62993 | |
| DSASKPAFGFGINSV | 806 | A8CG34 | |
| TFSTDPVNFPNKAEG | 341 | Q16821 | |
| AVFSVSDPDSGNNGK | 366 | Q9NRJ7 | |
| STAFNLQVATPGGKA | 36 | Q8NB37 | |
| VSFGSLQGAFQPKST | 36 | Q9HAH7 | |
| VGGKAASFTIPANSD | 1651 | Q6WRI0 | |
| NPNFTAPGQEFLSKS | 2346 | P51587 | |
| ANKITLTGFHSPFNG | 336 | Q6UXV0 | |
| NQFSTFFKGAITPVL | 401 | O60883 | |
| GFNGKVLFTISDGNT | 756 | Q8TDW7 | |
| NLFPGGFQVTTDTQK | 901 | Q674R7 | |
| ESPAFAKGNLTFTAQ | 41 | Q08334 | |
| AASKFGSPEVAVAGQ | 331 | Q9Y4F3 | |
| NVQPDFKISAEGSGL | 121 | Q8WV07 | |
| FNIDSGNGSIFTSKL | 431 | P55285 | |
| SFQVLANGATAASKP | 291 | Q8IX15 | |
| TNTDGFKEQGVTFPS | 251 | P49327 | |
| SHPGSGTKVQFNLQF | 551 | Q6UVJ0 | |
| QFAPFVGIFGSTKET | 246 | Q9NZJ4 | |
| VGIFGSTKETFINGN | 251 | Q9NZJ4 | |
| STKETFINGNFPGTF | 256 | Q9NZJ4 | |
| PGSGAEILKQLFFNS | 861 | Q8IZU8 | |
| SGDFTQGPQSAKTRF | 516 | P14778 | |
| ASGINLFTNSFEGPV | 176 | P07358 | |
| ASFFTLQPGKTNGSD | 66 | Q9H7T9 | |
| TAGQQGKGITFIFTD | 3001 | Q8TE73 | |
| VNSNGKESPGSSEFF | 481 | Q8N108 | |
| VKGFGPATAINVTTN | 576 | Q15262 | |
| SQTDFAFVTGNLIGK | 316 | Q99487 | |
| GSLFGFSFNAPLKSN | 1551 | P0DJD0 | |
| NKGVLSAFNFGTVPS | 1021 | O15397 | |
| LPAGTKVNGTFQANF | 171 | Q14954 | |
| PSGNSQDQGKFIALF | 266 | O76001 | |
| SFLKTIFPSQNGHDG | 66 | E9PJI5 | |
| SFLKTIFPSQNGHDG | 66 | P0DM63 | |
| LFGNNVTLASKFESG | 636 | P33402 | |
| FSKGFLNQESSGIPS | 516 | O15296 | |
| ISNEQDGDKGFLPTF | 346 | Q2WGJ9 | |
| GDKPISFEVSIGNFG | 496 | Q2WGJ9 | |
| GTSLSFSDKEGIQPF | 3546 | O75445 | |
| QNTGLGPEKTSFFQA | 126 | Q8NHW5 | |
| NARQSKPFASVVAGF | 421 | Q7L592 | |
| GKDASGQPIFNASAK | 321 | O15226 | |
| PTFSGQQIFALEKTF | 241 | P78426 | |
| SFLKTIFPSQNGHDG | 66 | E9PKD4 | |
| VGATFKLGDSLSNPN | 1401 | Q9HCM1 | |
| PNTQLFSKLVGSAFT | 336 | Q9BXS9 | |
| AQTGKSPAGVNLLSF | 636 | O43490 | |
| PNNKLGSGDDISVFV | 481 | Q5JR12 | |
| DFGFSNLFTPGQLLK | 206 | Q9Y2K2 | |
| TEPGQVKLADFGSAS | 156 | Q9H2K8 | |
| FRTFFGPGVNNKSAQ | 456 | Q96JW4 | |
| FAIATAGANEGTPNK | 906 | Q13972 | |
| GGSIANFTNVAATFK | 341 | P53396 | |
| QPSFSNLTAFPGGAK | 471 | Q99941 | |
| GGLKFFVPDISNSNS | 461 | Q9UQC9 | |
| DPQSSSAKGLQEGFG | 331 | P0CB48 | |
| AVFLVSSGPDGSQAK | 36 | Q6ZUT4 | |
| EPVTDNKAGFGNNFT | 871 | Q8N2C7 | |
| QSFEKQGFHSGTPAA | 991 | Q14157 | |
| TNAPGKDFQGISAAF | 96 | Q8IVF5 | |
| NSTISSAPKDFAIFG | 636 | Q9UH99 | |
| SFFKQIDSSPVGGET | 561 | O15027 | |
| QGPFSNSSEKVFVRG | 2756 | Q15772 | |
| ALPGQFVNSKGALFT | 381 | C9JR72 | |
| SAVKPQTLGGDSTFF | 21 | Q15431 | |
| TNEKLFFGSGTQLSV | 1 | A0A0J9YXG5 | |
| GAVTFSSQGRVNPFK | 901 | O75717 | |
| AASQAGVPFGLKNTS | 601 | Q8NEM7 | |
| GPVADAFNNSSISIK | 61 | O00624 | |
| AFKTQVGRFAPQFSG | 361 | Q9Y4E8 | |
| KNFFSKANGNRSGAP | 381 | Q6UXI7 | |
| TLVPNFTFNLGFSGK | 346 | P52849 | |
| AGKALGVISNFQSSP | 401 | O94876 | |
| KEQGVTFPAIGSQAA | 136 | Q92783 | |
| TPFQFGVSNLGQEEK | 996 | P49790 | |
| SPAAFTVGSNGKNVF | 1441 | P49790 | |
| QFSVLAQNKLGSGPF | 581 | Q9P2J2 | |
| LQVGFGKQVDSPSAT | 661 | Q9BZ95 | |
| SFANQKAFRGVNGSP | 336 | Q9H040 | |
| KPEGGPSFSQDTVFQ | 736 | P59923 | |
| DGLKFASVQASAPQG | 81 | Q9ULD9 | |
| AAIKGQNPSATFGDV | 271 | Q96NM4 | |
| FTTPSQAKGIDFQLF | 186 | A2RU30 | |
| KGQGATFVETDSPFT | 1821 | Q9C0G0 | |
| IGVGTETFLQGQFKS | 26 | A0PK05 | |
| KVFVALSSFPGAGNT | 351 | Q658N2 | |
| LFKQFTQPRNTGGDS | 246 | Q8IWB9 | |
| LKGQFTTDFDFSVPG | 3416 | Q9Y4A5 | |
| GKFVIFGATSLQNTG | 146 | Q9H2H9 | |
| TNPDGTTSKIFGFVA | 1356 | Q63HR2 | |
| AKVGSVQSPSAGFFF | 31 | Q6UXP3 | |
| LGSPGLKVTGFTFQN | 136 | P17097 | |
| GVPKQGDNFLSFSAA | 1411 | Q9BYP7 | |
| AGFPGTFSLQDKESV | 2061 | Q5THJ4 | |
| NGEQFKVSPGTLAFS | 896 | P32418 |